---
figid: PMC6097550__mmt-03-47-g1
figlink: /pmc/articles/PMC6097550/figure/F0001/
number: <b>Figure 1.</b>
caption: (A) In normal melanocytes, N-Ras is inactive until a stimulus (e.g., growth
  factor) binds its receptor tyrosine kinase, which promotes exchange of GDP to GTP
  by GEFs, thereby activating N-Ras. In normal melanocytes, activation of N-Ras signaling
  is mediated by the Raf-MEK-ERK pathway. (B) In NRAS mutant melanoma, the N-ras protein
  is unable to hydrolyze GTP to GDP, and remains in the GTP-bound, active state. Oncogenic
  N-Ras stimulates various Ras effector pathway, including Raf, PI3K/Akt, and RAL.
  Ras-Raf-MEK-ERK signaling drives cellular proliferation, as does the PI3K/Akt pathway.
  Downstream signaling can be disrupted via inhibition of MEK signaling, and in cooperation
  with MEK inhibition. Disruption of CDK4/6 signaling cooperates to disable tumor
  growth in NRAS mutant melanoma. There is some suggestion the response to immune
  checkpoint blockade is enhanced in patients with NRAS mutant melanoma, but the reports
  are limited and a proposed mechanism is lacking. Treatment of NRAS mutant melanoma
  (*) involves targeting MEK, PI3K/Akt, CDK4/6, or immune checkpoints (PD1, CTLA-4).
pmcid: PMC6097550
papertitle: 'NRAS mutant melanoma: an overview for the clinician for melanoma management.'
reftext: Russell W Jenkins, et al. Melanoma Manag. 2016 Mar;3(1):47-59.
pmc_ranked_result_index: '11093'
pathway_score: 0.9683914
filename: mmt-03-47-g1.jpg
figtitle: 'NRAS mutant melanoma: an overview for the clinician for melanoma management'
year: '2016'
organisms: Homo sapiens
ndex: 19bc8196-de9c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6097550__mmt-03-47-g1.html
  '@type': Dataset
  description: (A) In normal melanocytes, N-Ras is inactive until a stimulus (e.g.,
    growth factor) binds its receptor tyrosine kinase, which promotes exchange of
    GDP to GTP by GEFs, thereby activating N-Ras. In normal melanocytes, activation
    of N-Ras signaling is mediated by the Raf-MEK-ERK pathway. (B) In NRAS mutant
    melanoma, the N-ras protein is unable to hydrolyze GTP to GDP, and remains in
    the GTP-bound, active state. Oncogenic N-Ras stimulates various Ras effector pathway,
    including Raf, PI3K/Akt, and RAL. Ras-Raf-MEK-ERK signaling drives cellular proliferation,
    as does the PI3K/Akt pathway. Downstream signaling can be disrupted via inhibition
    of MEK signaling, and in cooperation with MEK inhibition. Disruption of CDK4/6
    signaling cooperates to disable tumor growth in NRAS mutant melanoma. There is
    some suggestion the response to immune checkpoint blockade is enhanced in patients
    with NRAS mutant melanoma, but the reports are limited and a proposed mechanism
    is lacking. Treatment of NRAS mutant melanoma (*) involves targeting MEK, PI3K/Akt,
    CDK4/6, or immune checkpoints (PD1, CTLA-4).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GNA13
  - MAP2K2
  - AKT1
  - AKT2
  - PIK3CA
  - BRAF
  - CDK4
  - AKT3
  - SLC2A4RG
  - PIK3CB
  - GNA12
  - CD274
  - PIK3R4
  - PIK3R3
  - PIK3R6
  - RASA1
  - CTLA4
  - MAPK3
  - MAPK1
  - PIK3R5
  - PIK3CD
  - PIK3CG
  - CDK6
  - MAP2K1
  - RAF1
  - PDCD1
  - RALA
  - NRAS
  - RALB
  - Cancer
genes:
- word: G12/13
  symbol: G12
  source: bioentities_symbol
  hgnc_symbol: GNA13
  entrez: '10672'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: B-RAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: GEF
  symbol: GEF
  source: hgnc_alias_symbol
  hgnc_symbol: SLC2A4RG
  entrez: '56731'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: G12/13
  symbol: G12
  source: bioentities_symbol
  hgnc_symbol: GNA12
  entrez: '2768'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: GAP
  symbol: GAP
  source: hgnc_alias_symbol
  hgnc_symbol: RASA1
  entrez: '5921'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: C-RAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: RAL
  symbol: RAL
  source: bioentities_symbol
  hgnc_symbol: RALA
  entrez: '5898'
- word: N-Ras
  symbol: N-ras
  source: hgnc_alias_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAL
  symbol: RAL
  source: bioentities_symbol
  hgnc_symbol: RALB
  entrez: '5899'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
